Exchange: OTC·Updated 09:30 AM EDT

THMO ThermoGenesis Holdings Inc

$0.0001
$0.00
(0.00%)
Today
Reported EarningsNov 13
Mkt Cap$1,585.00
Vol56.00

About THMO

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
54

Neutral Sentiment

How do you feel about THMO?

Advertisement|Remove ads.